Good Works II Acquisition in an 8-K disclosed plans to redeem shares and dissolve, effective March 16, as the SPAC will not be able to complete a merger before its deadline. The filing did not state an estimated per-share redemption price.
Good Works II last week called off a deal with Direct Biologics that was announced in October. The decision was mutual, the SPAC said.
Good Works II raised $200 million in a July 2021 IPO with plans to target “high-growth companies that need significant capital because of disruptions related to COVID-19 or other high-quality businesses experiencing high-growth.” Read more.
